Please login to the form below
Is HTML5 the nail in the coffin of Flash?
Its lack of compatibility with Apple devices has seriously handicapped Flash when it comes to the mobile web
With the advent of HTML5, the limitations of Flash may mean it has had its day.
And since Flash won't work on any Apple devices, a large section of the mobile web users are immediately excluded, which is a major drawback for anyone considering Flash content for their website.
It may be early days for HTML5, but it's hard to see how Flash will be able to compete in the long run.
22nd June 2012
Share
Related Hub content
Featured jobs
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Writer, Healthcare Advertising, London
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Systematic Review Lead- London
-
Negotiable
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Account Manager
-
Negotiable
- Sudler London - Senior Medical Writer
-
Competitive
-
Senior Medical Writer
-
Salary is DOE
-
Sudler London - Account Director
-
Competitive
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
Subscribe to our email news alerts
- Moving annual total (MAT)
- Key success factor (KSF)
- AZ prepares to file COPD triple, taking on rival GSK
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Gilead targets hep B in half a billion dollar deal with Precision BioSciences
- Teva wins FDA OK for crucial migraine drug
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
- Bayer roll-out of haemophilia drug Jivi gathers pace
PMHub
PRMA Consulting Ltd
PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...
Quick links
Infographics
